Experts suggest that generative AI models in medicine should be licensed similarly to doctors and nurses to ensure accountability and safety.
Key Details
- 1Academic, policy, and public health leaders propose a licensure framework for medical GenAI models, similar to those for clinicians.
- 2UPenn's Eric Bressman and collaborators published a JAMA Internal Medicine opinion highlighting this approach.
- 3A blog post by UPenn policy expert Julia Hinkley supports a federal digital licensing board overseeing medical AI.
- 4FDA could handle premarket review, while state boards might provide ongoing oversight and coordinate standards.
- 5The initiative aims to address concerns about AI hallucinations, performance drift, and maintain standards and accountability.
Why It Matters
As generative AI’s use grows in radiology and other areas, robust and harmonized regulation is critical to maintain quality, safety, and trust. Introducing a licensing system modeled after medical professions could help set clear expectations and mechanisms for oversight of clinical AI systems.
Source
HealthExec
Related News
•Radiology Business
NCCN Endorses AI Risk Tools for Breast Cancer Screening
NCCN's 2026 guidelines recommend routine integration of AI-based 5-year breast cancer risk prediction from mammograms.
•Radiology Business
ACR Expands Resources for Radiology Practices to Assess Imaging AI
The ACR is offering new tools to help radiology practices evaluate and monitor imaging AI algorithms.
•HealthExec
EFF Sues CMS For Transparency on AI-Powered Medicare Prior Authorization
EFF has sued CMS to compel disclosure about the WISeR pilot deploying AI for Medicare prior authorization.